Matches in Wikidata for { <http://www.wikidata.org/entity/Q90423745> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q90423745 description "article scientifique publié en 2019" @default.
- Q90423745 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90423745 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90423745 description "scientific article published on 01 October 2019" @default.
- Q90423745 description "wetenschappelijk artikel" @default.
- Q90423745 description "наукова стаття, опублікована 1 жовтня 2019" @default.
- Q90423745 name "How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?" @default.
- Q90423745 name "How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?" @default.
- Q90423745 type Item @default.
- Q90423745 label "How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?" @default.
- Q90423745 label "How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?" @default.
- Q90423745 prefLabel "How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?" @default.
- Q90423745 prefLabel "How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?" @default.
- Q90423745 P1433 Q90423745-52F2CC1E-C176-4A4C-A2AC-280AEA5C44F4 @default.
- Q90423745 P1476 Q90423745-F6CCC769-FC4C-4B12-890C-E05412F92E4A @default.
- Q90423745 P2093 Q90423745-A966C7D1-FD05-4592-A99D-DF4D4E96C88C @default.
- Q90423745 P2093 Q90423745-B1347385-C016-4F3C-9249-5938DDC500B1 @default.
- Q90423745 P2860 Q90423745-2D8CA791-E068-4CDA-B9B6-BFFD2CE2CC8A @default.
- Q90423745 P2860 Q90423745-3EA8ADF9-6D8D-434A-9270-22FDCC40ACDB @default.
- Q90423745 P2860 Q90423745-62FAB4F1-B9F8-44A3-9DD4-0221C06ACF9E @default.
- Q90423745 P2860 Q90423745-651411E3-CC6F-421B-8289-1889FF46FDF5 @default.
- Q90423745 P2860 Q90423745-66F59DC2-C1C9-4059-B77D-1D9781F6FD67 @default.
- Q90423745 P2860 Q90423745-97D36749-E594-478F-B7C8-0FEE75785FD4 @default.
- Q90423745 P2860 Q90423745-995D5E29-B3B3-469B-B514-0FBAD20DB023 @default.
- Q90423745 P2860 Q90423745-BFEA80D4-41ED-413E-A428-332E09782FD7 @default.
- Q90423745 P2860 Q90423745-C1190442-73EE-4258-8B59-241C0A3FDDFF @default.
- Q90423745 P2860 Q90423745-CD9E7C20-0EC2-4499-BB21-C00225F0A442 @default.
- Q90423745 P304 Q90423745-18BCF08F-8EBE-4025-976E-38F638C0F925 @default.
- Q90423745 P31 Q90423745-4BE1E7DA-CDC7-4484-A763-C4B9F2A7E661 @default.
- Q90423745 P356 Q90423745-7A8CB671-82FA-4AC1-A0F3-11AEB8564E5C @default.
- Q90423745 P433 Q90423745-C77EA9D6-BC99-4B53-9CFA-92A8E8C0A6FC @default.
- Q90423745 P478 Q90423745-E723C150-DFC4-4C99-A263-9A610CC2B883 @default.
- Q90423745 P577 Q90423745-EE10F82A-E4C6-4EB8-82C1-CF30384D77C2 @default.
- Q90423745 P698 Q90423745-433D89A6-4206-4A20-983E-2618F058F9E7 @default.
- Q90423745 P356 CJN.05340419 @default.
- Q90423745 P698 31575617 @default.
- Q90423745 P1433 Q15757929 @default.
- Q90423745 P1476 "How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?" @default.
- Q90423745 P2093 "Joshua J Neumiller" @default.
- Q90423745 P2093 "Rita R Kalyani" @default.
- Q90423745 P2860 Q34673134 @default.
- Q90423745 P2860 Q38254458 @default.
- Q90423745 P2860 Q38729780 @default.
- Q90423745 P2860 Q40206755 @default.
- Q90423745 P2860 Q53084508 @default.
- Q90423745 P2860 Q63170509 @default.
- Q90423745 P2860 Q90595532 @default.
- Q90423745 P2860 Q91148170 @default.
- Q90423745 P2860 Q92731317 @default.
- Q90423745 P2860 Q92980564 @default.
- Q90423745 P304 "1667-1669" @default.
- Q90423745 P31 Q13442814 @default.
- Q90423745 P356 "10.2215/CJN.05340419" @default.
- Q90423745 P433 "11" @default.
- Q90423745 P478 "14" @default.
- Q90423745 P577 "2019-10-01T00:00:00Z" @default.
- Q90423745 P698 "31575617" @default.